Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,
The artificial intelligence–based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.